Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription Articles published in Int J Radiat Oncol Biol Phys Retrieve available abstracts of 176 articles: HTML format

Single Articles

November 2027
1. TUPPER HI, Shrager JB, Moghanaki D, Simone CB 2nd, et al
   Misinformation and Overestimation of Computed Tomography Lung Cancer Screening Harms-Methodology Matters: A Joint Statement from The Society of Thoracic Surgeons, the American Society for Radiation Oncology, and the American College of Radiology.
   Int J Radiat Oncol Biol Phys. 2027 Nov 11:S0360-3016(25)06618.
   PubMed    
   
   
   September 2026
2. WANG S, Zhao F, Wang J, Hua Y, et al
   Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial.
   Int J Radiat Oncol Biol Phys. 2026;126:147-155.
   PubMed     Abstract available
   
   
   August 2026
3. ZHANG YH, Iqbal A, Gelblum D, Ma J, et al
   A Phase I Study of Cyclical Hypofractionated Palliative Radiotherapy (Quad Shot) for Central Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): Results from the PROMISE 006 Trial Thoracic Quad Shot RT in Stage IV NSCLC.
   Int J Radiat Oncol Biol Phys. 2026 Aug 18:S0360-3016(26)04202.
   PubMed     Abstract available
   
   
   
4. NGUYEN C, Chen J, Larner J, Colen J, et al
   Forecasting Time-Dependent Radiation Induced Lymphocyte Depletion in a Clinical Trial on Early-Stage Lung Cancer.
   Int J Radiat Oncol Biol Phys. 2026 Aug 18:S0360-3016(26)04190.
   PubMed     Abstract available
   
   
   
5. LU Y, Chen J, Sheng Y, Wang W, et al
   Comparing Different Planning Strategies for Pencil Beam Scanning Carbon Ion Radiotherapy for Stage I Peripheral Non-Small Lung Cancer: Toward Optimized Clinical Decision-Making.
   Int J Radiat Oncol Biol Phys. 2026 Aug 13:S0360-3016(26)04161.
   PubMed     Abstract available
   
   
   
6. BOSCH F, Damhuis R, Peters M, van Bockel LW, et al
   Real-world data on once or twice daily radiotherapy and the effect of age in patients with limited-stage small cell lung cancer.
   Int J Radiat Oncol Biol Phys. 2026 Aug 5:S0360-3016(26)04113.
   PubMed     Abstract available
   
   
   
7. VAN ROSSUM PSN, Damen PJJ, Cortiula F, Hobbs BP, et al
   Pretreatment Risk Model for Radiation-Induced Lymphopenia Is Associated With Adjuvant Durvalumab Efficacy in Patients With Unresectable Stage III NSCLC.
   Int J Radiat Oncol Biol Phys. 2026;125:1434-1444.
   PubMed     Abstract available
   
   
   July 2026
8. WILSON LJ, Castillo R, Castillo E, Jones B, et al
   Prospective Evaluation of Novel 4DCT-Ventilation Imaging for Preoperative Risk Assessment in Lung Cancer: Results of the LIME Trial.
   Int J Radiat Oncol Biol Phys. 2026 Jul 30:S0360-3016(26)04076.
   PubMed     Abstract available
   
   
   
9. LIM R, O'Connor CS, Pan J, Tang TT, et al
   Predicting end-of-treatment ventilation response to radiotherapy using early treatment ventilation for patients with lung cancer treated with photons and protons.
   Int J Radiat Oncol Biol Phys. 2026 Jul 28:S0360-3016(26)04068.
   PubMed     Abstract available
   
   
   
10. WIJESOORIYA K, Nguyen C, Conaway MR, Read PW, et al
    First Measurement: Proactively Sparing the Immune System During SBRT to Early-Stage Lung Cancer-A Randomized Phase II Study.
    Int J Radiat Oncol Biol Phys. 2026 Jul 22:S0360-3016(26)04026.
    PubMed     Abstract available
    
    
    
11. HOEKSTRA N, Kim DH, Vicini FA, Park S, et al
    The impact of breast radiation technique on secondary lung cancer risk modeling: An analysis based on clinically delivered lung doses of various modern radiation techniques and target volumes.
    Int J Radiat Oncol Biol Phys. 2026 Jul 8:S0360-3016(26)03943.
    PubMed     Abstract available
    
    
    
12. LIN R, Chen M, Zhang X, Xu T, et al
    Bayesian Learning to Reduce Cardiac Risk of Patients With Locally Advanced Non-Small Cell Lung Cancer Based on Personalized Radiation Therapy Prescription.
    Int J Radiat Oncol Biol Phys. 2026;125:949-958.
    PubMed     Abstract available
    
    
    June 2026
13. LI X, Wu Y, Zhang Y, Ge M, et al
    Dosimetric Parameters of the Heart and Its Substructures in Predicting Cardiac Events or Survival in Lung Cancer Patients After Radiotherapy: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2026 Jun 13:S0360-3016(26)00839.
    PubMed     Abstract available
    
    
    
14. RODRIGUEZ-RUSSO C, Chang L
    A PORT Yet Uncharted: The Evidence Gap for Postoperative Radiation Therapy Following Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026;125:370.
    PubMed    
    
    
    
15. LADBURY C, Chun SG
    When the Nodes Don't Get the Memo: New Era, Same Conclusion on Postoperative Radiation Therapy for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026;125:368.
    PubMed    
    
    
    May 2026
16. LINGYUN W, Nakamura M, Toru M, Jing Y, et al
    Longitudinal Plasma Proteomics Reveals an Immuno-thrombotic Signature that Predicts Radiation Pneumonitis in Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026 May 22:S0360-3016(26)00731.
    PubMed     Abstract available
    
    
    
17. SU T, Xu T, Chen M, Chen X, et al
    Long-term outcomes after proton therapy vs. intensity-modulated photon radiotherapy with concurrent chemotherapy for locally advanced non-small-cell lung cancer: post-hoc analysis of a prospective randomized trial.
    Int J Radiat Oncol Biol Phys. 2026 May 21:S0360-3016(26)00729.
    PubMed     Abstract available
    
    
    
18. JIANG Y, Yang Y, Wu L, Wang J, et al
    Peripheral PD-1(+)CD8(+) T-cell TCR Dynamics During Radiation Therapy Predict Survival in Unresectable Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026 May 16:S0360-3016(26)00574.
    PubMed     Abstract available
    
    
    
19. YANG J, Zhu T, Zhou J, Ni C, et al
    A Meta-Analysis-Based Risk Score for Predicting Radiation Pneumonitis After Thoracic Radiotherapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026 May 14:S0360-3016(26)00719.
    PubMed     Abstract available
    
    
    
20. BOGART JA, Wang X, Masters G, Komaki R, et al
    Brief Report: Mature Outcomes of 61.2 Gy Concomitant Boost Thoracic Radiotherapy in Limited Stage Small Cell Lung Cancer: CALGB 30610 (Alliance) / RTOG 0538.
    Int J Radiat Oncol Biol Phys. 2026 May 3:S0360-3016(26)00688.
    PubMed     Abstract available
    
    
    
21. CHETTY IJ, Zhong H
    Deformable Dose Mapping and Accumulation Techniques for Stereotactic Body Radiation Therapy (SBRT) of Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2026;125:86-101.
    PubMed     Abstract available
    
    
    
22. CEDOZ E, Levy A, Martel-Lafay I, Bondiau PY, et al
    Stereotactic Versus Standard Tumor Irradiation in Unresectable Locally Advanced Non-small Cell Lung Cancer With Durvalumab Maintenance: A Multicenter Study With Propensity Score Matching.
    Int J Radiat Oncol Biol Phys. 2026;125:112-122.
    PubMed     Abstract available
    
    
    
23. BAKER S, Leclerc C, Atmanspacher-Wirth H, Zhao Y, et al
    The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial.
    Int J Radiat Oncol Biol Phys. 2026;125:102-111.
    PubMed     Abstract available
    
    
    April 2026
24. KAO CF, Sheu RJ, Peir JJ, Wu YH, et al
    Development and Application of a Simplified Mathematical Model for The Estimation of Tumor Dose of Non-Small Cell Lung Cancer in BNCT.
    Int J Radiat Oncol Biol Phys. 2026 Apr 21:S0360-3016(26)00596.
    PubMed     Abstract available
    
    
    
25. LEVIN N, Killingberg KT, Halvorsen TO, Danielsen S, et al
    Erratum to 'Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.' International Journal of Radiation Oncology*Biology*Phy
    Int J Radiat Oncol Biol Phys. 2026 Apr 3:S0360-3016(26)00512.
    PubMed    
    
    
    
26. KARLSSON K, Rancati T, Lindback E, Lindberg S, et al
    Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort.
    Int J Radiat Oncol Biol Phys. 2026;124:1298-1308.
    PubMed     Abstract available
    
    
    
27. FUCHS F, Herrera R, Kotecha R, Rubens M, et al
    Multi-institutional Analysis of MR-Guided Single-Fraction Stereotactic Ablative Body Radiation Therapy: Feasibility, Safety, and Efficacy.
    Int J Radiat Oncol Biol Phys. 2026;124:1421-1430.
    PubMed     Abstract available
    
    
    
28. ABI JAOUDE J, Cui S, Fu J, Worth JE, et al
    Local Control in Thoracic Stereotactic Ablative Radiation Therapy: Analysis of Motion Management and Single-Fraction Dosimetry From the iSABR Trial.
    Int J Radiat Oncol Biol Phys. 2026;124:1309-1317.
    PubMed     Abstract available
    
    
    
29. SALUNKHE R, Palma DA, Warner A, Bahig H, et al
    Dosimetric Outcomes of Stereotactic Body Radiation Therapy to Ultracentral Lung Tumors: Lessons From the SUNSET Trial.
    Int J Radiat Oncol Biol Phys. 2026;124:1290-1297.
    PubMed     Abstract available
    
    
    March 2026
30. ADIB E, Willers H, Samson PP, Robinson CG, et al
    Integration of Immune Checkpoint Blockade With Radiation in Lung Cancer: Lessons From Recent Trials.
    Int J Radiat Oncol Biol Phys. 2026;124:887-891.
    PubMed    
    
    
    
31. ZRAFI WS, Albarran-Artahona V, Dall'Olio FG, Ghigna MR, et al
    Tumor purity as a prognostic and predictive biomarker of postoperative radiotherapy outcomes in stage IIIA-N2 non-small-cell lung cancer: a transcriptomic analysis from the Lung ART trial.
    Int J Radiat Oncol Biol Phys. 2026 Mar 13:S0360-3016(26)00491.
    PubMed     Abstract available
    
    
    
32. SINGH AK, Farrugia MK, Stephans KL, Bogart JA, et al
    Long-term Analysis of One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2026 Mar 13:S0360-3016(26)00487.
    PubMed     Abstract available
    
    
    
33. ITO S, Nakajima Y, Fujita Y, Capaldi DPI, et al
    Comparison of Computed Tomography Ventilation Imaging and Hyperpolarized (3)He Magnetic Resonance Imaging in Patients with Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026 Mar 7:S0360-3016(26)00480.
    PubMed     Abstract available
    
    
    February 2026
34. BARRETT S, Zahid M, McGarry CK, Enderling H, et al
    External Validation of The Proliferation Saturation Index Model in Predicting Tumour Volume Regression in Patients with Non-Small Cell Lung Cancer Undergoing Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2026 Feb 20:S0360-3016(26)00399.
    PubMed     Abstract available
    
    
    
35. REUTER LM, Kraus KM, Fischer SM, Pletzer D, et al
    Prediction of Symptomatic Radiation Pneumonitis in Lung Cancer Patients: A Radiomics and Dosiomics Machine Learning Approach Using the Prospective Multicenter RTOG 0617 and REQUITE trials.
    Int J Radiat Oncol Biol Phys. 2026 Feb 18:S0360-3016(26)00365.
    PubMed     Abstract available
    
    
    
36. MILGROM SA, Paganetti H, Dama H, Renfro L, et al
    Subsequent Neoplasm Risk after Modern Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Insights from a Multi-Institutional Children's Oncology Group Trial.
    Int J Radiat Oncol Biol Phys. 2026 Feb 6:S0360-3016(26)00361.
    PubMed     Abstract available
    
    
    
37. LIN CS, Shen C, Banks T, Prasad R, et al
    Feasibility, Workflow, Dosimetry and PET Signal Trends in Lung Cancer Treated with Biology-Guided Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2026 Feb 4:S0360-3016(25)06621.
    PubMed     Abstract available
    
    
    
38. WIMMERT L, Gauer T, Dickmann J, Hofmann C, et al
    Dose Reduction in 4-Dimensional Computed Tomography Imaging: Breathing Signal-Guided Deep Learning-Driven Data Acquisition.
    Int J Radiat Oncol Biol Phys. 2026;124:512-521.
    PubMed     Abstract available
    
    
    
39. SAID BI, Boukhaled GM, Lok BH, Lukovic J, et al
    Cross-Cancer Analysis Reveals a Distinct Pattern of Immune Modulation During Curative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2026;124:441-450.
    PubMed     Abstract available
    
    
    January 2026
40. ZHAI T, Toprani SM, Dillon-Martin M, Doyle PF, et al
    Telomere Length Dynamics As a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2026 Jan 14:S0360-3016(26)00064.
    PubMed     Abstract available
    
    
    
41. SIMONE CB 2ND
    A Potential Path Toward Finally Improving Outcomes With Concurrent Immunotherapy and Chemoradiation for Lung Cancer: Low-Dose Radiation Therapy Lessons From the MATCH Trial in Extensive-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2026;124:174-176.
    PubMed    
    
    
    December 2025
42. MA J, Yu H, Zhang X, Yuan J, et al
    Skull Dosimetry for Mitigating Acute Hematologic Toxicity in NSCLC Patients with Brain Metastases Undergoing Cranial Radiotherapy and Immunotherapy.
    Int J Radiat Oncol Biol Phys. 2025 Dec 24:S0360-3016(25)06623.
    PubMed     Abstract available
    
    
    
43. CAMMARERI E, Duijm M, Granton PV, Schillemans W, et al
    High dose REirradiation for in-field recurrent Lung Cancer in the THOrax (RETHO): outcomes of a phase 2 prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2025 Dec 20:S0360-3016(25)06616.
    PubMed     Abstract available
    
    
    
44. KOTHARI G, O'Byrne KJ, Brown C, Stockler MR, et al
    A Randomized Phase 2 Trial of Nivolumab and Stereotactic Ablative Body Radiotherapy (SABR) in Advanced Non-Small Cell Lung Cancer, Progressing After First- or Second-Line Chemotherapy (NIVORAD).
    Int J Radiat Oncol Biol Phys. 2025 Dec 19:S0360-3016(25)06610.
    PubMed     Abstract available
    
    
    
45. THOMPSON LL, Amin PM, Shah S, Lipson SM, et al
    Associations Between G8 Geriatric Screening Score, Charlson Comorbidity Index, AI-Based Age Phenotype, and Overall Survival in Older Adults With Stage I-II Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;123:1295-1305.
    PubMed     Abstract available
    
    
    November 2025
46. ZHAO J, Vaios E, Calabrese E, Yang Z, et al
    An Explainable Deep Model for Risk Scoring and Accurate Radionecrosis Identification Following Brain Metastasis Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2025 Nov 27:S0360-3016(25)06522.
    PubMed     Abstract available
    
    
    
47. HOU Q, Parpia S, Wierzbicki M, Kundapur V, et al
    Quality of Life of Stereotactic vs. Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results from the XXXXXX trial.
    Int J Radiat Oncol Biol Phys. 2025 Nov 21:S0360-3016(25)06498.
    PubMed     Abstract available
    
    
    
48. LI GJ, Soon MS, Chen H, Boldt G, et al
    Treatment Toxicity and Outcomes Following Definitive Radiation Therapy for Patients With Early-Stage Non-Small Cell Lung Cancers and Pre-Existing Interstitial Lung Disease-A Systematic Review and Dosimetric Analysis.
    Int J Radiat Oncol Biol Phys. 2025;123:1050-1060.
    PubMed     Abstract available
    
    
    
49. AVERBUCH I, Appel S, Blumenfeld P, Goltser A, et al
    Assessment of the Effective Dose to Immune Cells as an Independent predictor of Durvalumab response in Non-Small Cell Lung Cancer patients after Chemoradiotherapy: A Multi-Center Study.
    Int J Radiat Oncol Biol Phys. 2025 Nov 14:S0360-3016(25)06478.
    PubMed     Abstract available
    
    
    October 2025
50. CHEN X, Zhang X, Xu T, Mohan R, et al
    Radiation doses to cardiac substructures predict elevation in high-sensitivity cardiac troponin T (hs-cTnT) levels in radiotherapy for lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Oct 17:S0360-3016(25)06388.
    PubMed     Abstract available
    
    
    
51. ZHAN TY, Zhang T, Wang WQ, Deng L, et al
    Simultaneous Integrated Dose Reduction Radiotherapy Versus Conventional Fractionated Radiotherapy With Chemotherapy for Limited-Stage Small-Cell Lung Cancer in the Modern Treatment Era: a Phase III, Randomized Clinical Trial (SDR-RT trial).
    Int J Radiat Oncol Biol Phys. 2025 Oct 14:S0360-3016(25)06331.
    PubMed     Abstract available
    
    
    
52. MORRIS T, Muradova Z, Brown N, Carmes L, et al
    Second-Generation Gadolinium-Bismuth Ultrasmall Nanoparticles Amplify the Effects of Clinical Radiation Therapy and Provide Clinical Magnetic Resonance Imaging Contrast.
    Int J Radiat Oncol Biol Phys. 2025;123:572-582.
    PubMed     Abstract available
    
    
    
53. TOM MC, Wang K, Edwards DM, Huang J, et al
    Electrifying Results? Tumor Treating Fields Reduce Intracranial Relapse of Non-Small Cell Lung Cancer Brain Metastasis Following Radiosurgery in the METIS Trial.
    Int J Radiat Oncol Biol Phys. 2025 Oct 1:S0360-3016(25)06224.
    PubMed    
    
    
    September 2025
54. MEHTA MP, Gondi V, Ahluwalia MS, Roberge D, et al
    Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study.
    Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06217.
    PubMed     Abstract available
    
    
    
55. DANG A, Palma DA, Wang E, Lang P, et al
    Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial.
    Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06288.
    PubMed     Abstract available
    
    
    
56. LI Q, Ma H, Zheng R, Cai L, et al
    Durvalumab combined with chemotherapy and Stereotactic Ablative Body Radiotherapy (SABR) in patients with oligometastatic non-small cell lung cancer: a multi-center phase 2 study.
    Int J Radiat Oncol Biol Phys. 2025 Sep 24:S0360-3016(25)06304.
    PubMed     Abstract available
    
    
    
57. ARCIDIACONO F, Anselmo P, Casale M, Zannori C, et al
    5-year survival and safety of stereotactic ablative radiotherapy in unresectable locally advanced non-small cell lung cancer patients unfit for concurrent radio-chemotherapy:focus on patterns of local recurrence from the START-NEW-ERA non-randomized p
    Int J Radiat Oncol Biol Phys. 2025 Sep 22:S0360-3016(25)06209.
    PubMed     Abstract available
    
    
    
58. FRIEDES C, Yegya-Raman N, Iocolano M, Levin WP, et al
    Primary Tumor Failure after Definitive Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Brief Report on the Implications for NRG LU-008.
    Int J Radiat Oncol Biol Phys. 2025 Sep 16:S0360-3016(25)06276.
    PubMed     Abstract available
    
    
    
59. RUTKOWSKI J, Nowicka Z, Sobocki BK, Slebioda T, et al
    Patterns of immunity changes predict response to stereotactic ablative radiotherapy in early non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Sep 3:S0360-3016(25)06206.
    PubMed     Abstract available
    
    
    August 2025
60. WANG W, Ren M, Ren J, Dang J, et al
    Predicting Radiation Pneumonitis Integrating Clinical Information, Medical Text, and 2.5D Deep Learning Features in Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Aug 21:S0360-3016(25)06035.
    PubMed     Abstract available
    
    
    
61. GEWIRTZ A, Yang JT
    Leptomeningeal Spread in EGFR-Mutant Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:1086-1087.
    PubMed    
    
    
    
62. ROGAWSKI D, Nagpal S
    Hold Your Fire: The Case for Targeted Therapy, Not Radiation, for EGFR-mutant Non-small Cell Lung Cancer Leptomeningeal Disease.
    Int J Radiat Oncol Biol Phys. 2025;122:1084.
    PubMed    
    
    
    
63. GAL O, Kotecha R
    Leptomeningeal Spread in EGFR Mutation Non-Small Cell Lung Cancer: No More One Size Fits All.
    Int J Radiat Oncol Biol Phys. 2025;122:1084-1086.
    PubMed    
    
    
    
64. HAISRAELY O, Tom MC
    Beneath the Surface: Peeling Back Layers of Management Complexity for Leptomeningeal Disease From EGFR-mutant Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:1082-1083.
    PubMed    
    
    
    July 2025
65. MONTI S, Giuseppe P, Caroprese M, Cella L, et al
    External Validation of Dose Patterns and Dosimetric Predictors for Radiation-Induced Esophagitis in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06043.
    PubMed     Abstract available
    
    
    
66. MAURY P, Sayous Y, Marnaoui R, Loiseau C, et al
    Stereotactic Ablative Radiotherapy (SABR) Quality and Survival of Patients with Head and Neck Cancer: a post-hoc analysis of the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2025 Jul 24:S0360-3016(25)06019.
    PubMed     Abstract available
    
    
    
67. LIU Y, Ma N, Li Y, Fan X, et al
    Relative Biological Effectiveness Derived from NTCP Analysis of Carbon Ion vs. Photon Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 21:S0360-3016(25)06016.
    PubMed     Abstract available
    
    
    
68. SAMSON P, Robinson C
    How to Avoid Collapsing Under the Pressure of Managing Atelectasis During Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:785.
    PubMed    
    
    
    
69. MEYER S, Hu YC, Rimner A, Mechalakos J, et al
    Deformable Image Registration Uncertainty-Encompassing Dose Accumulation for Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:818-826.
    PubMed     Abstract available
    
    
    
70. CHUONG MD, Mittauer KE, Bassetti MF, Rojas C, et al
    Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction (SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2025;122:957-967.
    PubMed     Abstract available
    
    
    
71. CORN BW, Paulus R, Gondi V, Mehta MP, et al
    "Hope" Drives Quality of Life in Patients with Brain Metastases, But, the "Hope Center" Remains Elusive: An Analysis of NRG-CC003.
    Int J Radiat Oncol Biol Phys. 2025 Jul 2:S0360-3016(25)04519.
    PubMed     Abstract available
    
    
    
72. AKDEMIR EY, Herrera R, Gurdikyan S, Hodgson LC, et al
    Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All Paradigm.
    Int J Radiat Oncol Biol Phys. 2025;122:739-751.
    PubMed     Abstract available
    
    
    
73. ZHOU L, Sun J, Xie C, Kang K, et al
    Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a multicenter, single-arm, phase 2 trial (MATCH).
    Int J Radiat Oncol Biol Phys. 2025 Jul 1:S0360-3016(25)04508.
    PubMed     Abstract available
    
    
    June 2025
74. ZHANG SC, Kehayias CE, Guthier C, He J, et al
    Differential Impact of Left Ventricular Myocardium and Left Coronary Radiation Dose with Incident Heart Failure and Coronary Events in Lung Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04493.
    PubMed     Abstract available
    
    
    
75. DUAN J, Zhu Y, Jiang W, Wang W, et al
    Risk-Based Local Radiation Therapy in Oligometastatic Non-small Cell Lung Cancer in the Era of Immunotherapy: A Multicentric Cohort Study.
    Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04499.
    PubMed     Abstract available
    
    
    
76. ZHANG Y, Laine AM, Iyengar P, Westover KD, et al
    Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2025;122:374-382.
    PubMed     Abstract available
    
    
    
77. OHRI N, Bodner WR, Kabarriti R, Shankar V, et al
    Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT).
    Int J Radiat Oncol Biol Phys. 2025;122:365-373.
    PubMed     Abstract available
    
    
    May 2025
78. KNOTH J, Nout RA, Potter R, Mahantshetty DU, et al
    Distant metastasis after chemoradiation and IGABT in locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 10:S0360-3016(25)00436.
    PubMed     Abstract available
    
    
    
79. KEANE F, Daly M, Louie A, Harris J, et al
    Resistance is Futile: Stereotactic Body Radiation Therapy for Oligoprogressive Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:1-4.
    PubMed    
    
    
    April 2025
80. ALFAIFI SA, Louie AV, Siva S, Guckenberger M, et al
    International Patterns of Practice for Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?: Global patterns of practice for SABR for early-stage NSCLC.
    Int J Radiat Oncol Biol Phys. 2025 Apr 29:S0360-3016(25)00390.
    PubMed     Abstract available
    
    
    
81. SIMONE CB 2ND, Amini A, Chetty IJ, Choi JI, et al
    American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-small Cell Lung Cancer Executive Summary.
    Int J Radiat Oncol Biol Phys. 2025 Apr 2:S0360-3016(25)00259.
    PubMed     Abstract available
    
    
    
82. PAN S, Chang CW, Tian Z, Wang T, et al
    Data-Driven Volumetric Computed Tomography Image Generation From Surface Structures Using a Patient-Specific Deep Leaning Model.
    Int J Radiat Oncol Biol Phys. 2025;121:1349-1360.
    PubMed     Abstract available
    
    
    
83. HUANG YH, Li Z, Xiong T, Chen Z, et al
    Constructing Surrogate Lung Ventilation Maps From 4-Dimensional Computed Tomography-Derived Subregional Respiratory Dynamics.
    Int J Radiat Oncol Biol Phys. 2025;121:1328-1338.
    PubMed     Abstract available
    
    
    March 2025
84. COOKE SA, Belderbos JSA, Stam B, Reymen B, et al
    Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost Trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 28:S0360-3016(25)00228.
    PubMed     Abstract available
    
    
    
85. MONTALVO SK, Lue B, Kakadiaris E, Ahn C, et al
    Global Longitudinal Strain: A Potential Non-invasive Tool for Early Detection of Radiation-Induced Cardiac Dysfunction in Lung Cancer Patients Receiving Thoracic Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025 Mar 27:S0360-3016(25)00257.
    PubMed     Abstract available
    
    
    
86. CHEN X, Meng F, Zhang P, Wang L, et al
    Establishing a deep learning model that integrates pre- and mid-treatment computed tomography to predict treatment response for non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Mar 13:S0360-3016(25)00243.
    PubMed     Abstract available
    
    
    
87. ALLEN SG, Schonewolf CA, Schipper MJ, Yin HM, et al
    Dosimetry and Toxicity Comparison of Three-Dimensional Conformal Radiation Therapy and Intensity-Modulated Radiation Therapy in Locally Advanced Lung Cancer Across a Large Statewide Quality Collaborative.
    Int J Radiat Oncol Biol Phys. 2025 Mar 10:S0360-3016(25)00236.
    PubMed     Abstract available
    
    
    
88. RIMNER A, Dejonckheere CS, Sahlmann J, Barth SA, et al
    Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan Trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 5:S0360-3016(25)00196.
    PubMed     Abstract available
    
    
    
89. BROOKS FMD, Glenn MC, Hernandez V, Saez J, et al
    Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?
    Int J Radiat Oncol Biol Phys. 2025;121:811-821.
    PubMed     Abstract available
    
    
    February 2025
90. XIAO L, Li Y, Wang S, Fan L, et al
    Early prediction of radiation pneumonitis in patients with lung cancer treated with immunotherapy through monitoring of plasma chemokines.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00151.
    PubMed     Abstract available
    
    
    
91. GAETA B, Eichholz JE, Walch H, Ilica AT, et al
    Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with SRS.
    Int J Radiat Oncol Biol Phys. 2025 Feb 8:S0360-3016(25)00093.
    PubMed     Abstract available
    
    
    
92. MA N, Ming X, Chen J, Jiang GL, et al
    Carbon ion radiotherapy with pencil beam scanning for stage III non-small cell lung cancer: toxicity profiles, survival outcomes, and prognostic indicators.
    Int J Radiat Oncol Biol Phys. 2025 Feb 5:S0360-3016(25)00094.
    PubMed     Abstract available
    
    
    
93. SHIN YS, Yun JK, Jung J, Park JH, et al
    Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:432-441.
    PubMed     Abstract available
    
    
    January 2025
94. LATIFI A, Roumeliotis M, Quirk S, Gardner UG, et al
    Brachytherapy Seed Placement by Robotic Bronchoscopy with Cone-Beam CT Guidance for Peripheral Lung Cancer: A Human Cadaveric Feasibility Pilot.
    Int J Radiat Oncol Biol Phys. 2025 Jan 25:S0360-3016(25)00078.
    PubMed     Abstract available
    
    
    
95. NAGLER F, Vorbach S, Mohamed AA, Thaqi S, et al
    Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
    Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771.
    PubMed     Abstract available
    
    
    
96. SCHELLENBERG D, Gabos Z, Duimering A, Debenham B, et al
    Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:28-38.
    PubMed     Abstract available
    
    
    
97. WANG E, Abdallah H, Snir J, Chong J, et al
    Predicting the 3-Dimensional Dose Distribution of Multilesion Lung Stereotactic Ablative Radiation Therapy With Generative Adversarial Networks.
    Int J Radiat Oncol Biol Phys. 2025;121:250-260.
    PubMed     Abstract available
    
    
    
98. WANG Y, Dong X, Yan S, Liu B, et al
    Comparison of the Long-term Survival Outcome of Surgery versus Stereotactic Body Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from Colorectal Cancer: A Propensity Score Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:45-55.
    PubMed     Abstract available
    
    
    December 2024
99. BARRETT S, Zahid MU, Enderling H, Marignol L, et al
    Predicting Individual Tumor Response Dynamics in Locally Advanced Non-Small Cell Lung Cancer Radiation Therapy: A Mathematical Modelling Study.
    Int J Radiat Oncol Biol Phys. 2024 Dec 3:S0360-3016(24)03563.
    PubMed     Abstract available
    
    
    November 2024
100. KEANE FK, Yeap BY, Khandekar MJ, Lin JJ, et al
     Phase II trial of consolidative stereotactic body radiation therapy in patients with metastatic oncogene-driven non-small cell lung carcinoma treated with tyrosine kinase inhibitors.
     Int J Radiat Oncol Biol Phys. 2024 Nov 20:S0360-3016(24)03515.
     PubMed     Abstract available
     
     
     
101. DOHOPOLSKI M, Schmitt LG, Anand S, Zhang H, et al
     Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment.
     Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03641.
     PubMed     Abstract available
     
     
     
102. ZHAO X, Huang S, Lin H, Choi JI, et al
     A Novel Dose Rate Optimization Method to Maximize Ultrahigh-Dose-Rate Coverage of Critical Organs at Risk Without Compromising Dosimetry Metrics in Proton Pencil Beam Scanning FLASH Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2024;120:1181-1191.
     PubMed     Abstract available
     
     
     
103. SIMONE CB 2ND
     Enhancing Outcomes in Locally Advanced Non-Small Cell Lung Cancer Through Stereotactic Dose Escalation.
     Int J Radiat Oncol Biol Phys. 2024;120:695-697.
     PubMed    
     
     
     
104. SAMSON P, Harris JP
     Here Comes the Sun: Continuing to Refine the Treatment of Ultracentral Non-Small Cell Lung Cancers.
     Int J Radiat Oncol Biol Phys. 2024;120:678-680.
     PubMed    
     
     
     
105. ZHANG S, Simard M, Lapointe A, Filion E, et al
     Evaluation of Radiation Dose Effect on Lung Function Using Iodine Maps Derived From Dual-Energy Computed Tomography.
     Int J Radiat Oncol Biol Phys. 2024;120:894-903.
     PubMed     Abstract available
     
     
     October 2024
106. WEISMAN M, Durm G, Shields MD, Hanna NH, et al
     Evaluation of Radiation Pneumonitis in a Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer (NSCLC): Big Ten
     Int J Radiat Oncol Biol Phys. 2024 Oct 25:S0360-3016(24)03450.
     PubMed     Abstract available
     
     
     
107. SADDOUGHI SA, Kern R
     Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) Lining: We Can All Have a Piece of the Pie.
     Int J Radiat Oncol Biol Phys. 2024;120:357-358.
     PubMed    
     
     
     
108. MCCALL NS, Higgins KA
     Toward the Optimal Delivery of Twice-Daily Thoracic Chemoradiation in Limited-Stage Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2024;120:343-344.
     PubMed    
     
     
     
109. JABBOUR SK, Higgins KA, Yom SS, Goodman KA, et al
     Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
     Int J Radiat Oncol Biol Phys. 2024;120:309-314.
     PubMed    
     
     
     
110. LI GJ, Tan H, Nusrat H, Chang J, et al
     Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review.
     Int J Radiat Oncol Biol Phys. 2024;120:359-369.
     PubMed     Abstract available
     
     
     
111. KAMTAM DN, Binkley MS, Kapula N, Sadeghi C, et al
     First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema.
     Int J Radiat Oncol Biol Phys. 2024;120:345-356.
     PubMed     Abstract available
     
     
     September 2024
112. IGARASHI A, Onishi H, Shioyama Y, Matsumoto Y, et al
     Cost-Utility Analysis of Stereotactic Body Radiation Therapy Versus Surgery for Patients With Stage I Non-small Cell Lung Cancer in Japan.
     Int J Radiat Oncol Biol Phys. 2024 Sep 28:S0360-3016(24)03174.
     PubMed     Abstract available
     
     
     
113. GENSHEIMER MF, Kotha NV, Vitzthum LK, Chin AL, et al
     A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2024 Sep 25:S0360-3016(24)03410.
     PubMed     Abstract available
     
     
     
114. MACMANUS MP, Prins E, Xie J, Akhurst T, et al
     Dose-response relationships between radiation exposure, bone marrow function as measured by (18)F-FLT PET, and lymphocyte counts during chemoradiation for non-small cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2024 Sep 2:S0360-3016(24)03290.
     PubMed     Abstract available
     
     
     
115. RANKINE LJ, Lu J, Wang Z, Kelsey CR, et al
     Quantifying Regional Radiation-Induced Lung Injury in Patients Using Hyperpolarized (129)Xe Gas Exchange Magnetic Resonance Imaging.
     Int J Radiat Oncol Biol Phys. 2024;120:216-228.
     PubMed     Abstract available
     
     
     August 2024
116. ZHANG Y, Iyengar P, Montalvo S, Westover KD, et al
     Concerning safety and efficacy of concurrent and consolidative durvalumab with thoracic radiotherapy in PDL1-unselected stage III non-small cell lung cancer: brief report.
     Int J Radiat Oncol Biol Phys. 2024 Aug 13:S0360-3016(24)03177.
     PubMed     Abstract available
     
     
     
117. TAN VS, Correa RJM, Nguyen TK, Louie AV, et al
     Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes.
     Int J Radiat Oncol Biol Phys. 2024 Aug 8:S0360-3016(24)03173.
     PubMed     Abstract available
     
     
     
118. GRONBERG BH
     Are We Finally Ready to Implement Twice-Daily Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer?
     Int J Radiat Oncol Biol Phys. 2024;119:1391-1392.
     PubMed    
     
     
     
119. LEAVITT RJ, Almeida A, Grilj V, Montay-Gruel P, et al
     Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2024;119:1493-1505.
     PubMed     Abstract available
     
     
     
120. PORTIER L, Daira P, Fourmaux B, Heinrich S, et al
     Differential Remodeling of the Oxylipin Pool After FLASH Versus Conventional Dose-Rate Irradiation In Vitro and In Vivo.
     Int J Radiat Oncol Biol Phys. 2024;119:1481-1492.
     PubMed     Abstract available
     
     
     July 2024
121. HARRIS JP, Samson P, Owen D, Siva S, et al
     Adapt or Perish: Adaptive RT for NSCLC.
     Int J Radiat Oncol Biol Phys. 2024;119:1047-1051.
     PubMed    
     
     
     
122. LIU W, Feng H, Taylor PA, Kang M, et al
     NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies.
     Int J Radiat Oncol Biol Phys. 2024;119:1208-1221.
     PubMed     Abstract available
     
     
     
123. EDWARDS DM, Schonewolf CA, Rice JD, Schipper M, et al
     Phase II Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients with Locally Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2024 Jul 4:S0360-3016(24)00749.
     PubMed     Abstract available
     
     
     
124. 
     Erratum to: Zeng Y, Liu Q, Wang Y, et al. CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer. Int J Radiat Oncol Biol Phys 2020;108(3):758-769.
     Int J Radiat Oncol Biol Phys. 2024;119:1030-1031.
     PubMed    
     
     
     
125. 
     Erratum to: Simone CB 2nd, Serebrenik AA, Gore EM, et al. Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Ph
     Int J Radiat Oncol Biol Phys. 2024;119:1029.
     PubMed    
     
     
     
126. HARRISON N, Kang M, Liu R, Charyyev S, et al
     A Novel Inverse Algorithm To Solve the Integrated Optimization of Dose, Dose Rate, and Linear Energy Transfer of Proton FLASH Therapy With Sparse Filters.
     Int J Radiat Oncol Biol Phys. 2024;119:957-967.
     PubMed     Abstract available
     
     
     June 2024
127. NI J, Chen H, Yu L, Guo T, et al
     Predicting regional recurrence and prognosis in stereotactic body radiotherapy-treated clinical stage I non-small cell lung cancer using a radiomics model constructed with surgical data.
     Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00743.
     PubMed     Abstract available
     
     
     
128. CASEY DL, Vogelius IR, Brodin NP, Roberts KB, et al
     Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.
     Int J Radiat Oncol Biol Phys. 2024;119:640-654.
     PubMed     Abstract available
     
     
     May 2024
129. LEE HI, Choi EK, Kim SS, Shin YS, et al
     Local Ablative Therapy Combined with Pembrolizumab in Patients with Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis.
     Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00674.
     PubMed     Abstract available
     
     
     April 2024
130. MIDRONI J, Salunkhe R, Liu Z, Chow R, et al
     Incorporating functional lung imaging (FLI) into radiation therapy planning in patients with lung cancer: A systematic review and meta-analysis.
     Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00481.
     PubMed     Abstract available
     
     
     
131. ZHANG Q, Fan S, Xu X, Du S, et al
     Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy with Helical TomoTherapy versus Conventional Radiotherapy in Patients with Unresectable Stage III Non-Small-Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicentre, Randomized
     Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00450.
     PubMed     Abstract available
     
     
     
132. MEREDITH EG, Filion E, Faria S, Kundapur V, et al
     Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET).
     Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00480.
     PubMed     Abstract available
     
     
     
133. LOMBARDO J, Castillo E, Castillo R, Miller R, et al
     Prospective trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report.
     Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00476.
     PubMed     Abstract available
     
     
     
134. LEVIN N, Killingberg KT, Halvorsen TO, Danielsen S, et al
     Evaluation of radiotherapy treatment plans in a randomized phase II trial comparing two schedules of twice-daily thoracic radiotherapy in limited stage small-cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00475.
     PubMed     Abstract available
     
     
     
135. VITZTHUM LK, Surucu M, Gensheimer MF, Kovalchuk N, et al
     BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy.
     Int J Radiat Oncol Biol Phys. 2024;118:1172-1180.
     PubMed     Abstract available
     
     
     
136. HUANG HT, Brand DH, Fenwick JD, Hawkins MA, et al
     Immuno-chemoradiation for non-small cell lung cancer: A meta-analysis of factors influencing survival benefit in combination trials.
     Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00449.
     PubMed     Abstract available
     
     
     March 2024
137. KIM KH, Kang N, Song SY, Kim HJ, et al
     Safety and efficacy of HL301 in radiation pneumonitis in patients with unresectable non-small cell lung cancer receiving curative concurrent chemoradiotherapy: A multicenter, randomized, double-blinded, placebo-controlled, phase IIa clinical trial.
     Int J Radiat Oncol Biol Phys. 2024 Mar 31:S0360-3016(24)00447.
     PubMed     Abstract available
     
     
     
138. FAROOQI AS, Yoder AK, Lin HY, Pasalic D, et al
     SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.
     Int J Radiat Oncol Biol Phys. 2024;118:971-978.
     PubMed     Abstract available
     
     
     
139. LUCIA F, Bourhis D, Pinot F, Hamya M, et al
     Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium 68 Perfusion Positron Emission Tomography/Computed Tomography.
     Int J Radiat Oncol Biol Phys. 2024;118:952-962.
     PubMed     Abstract available
     
     
     
140. LIU YC, Schmidt RO, Kapadia NS, Phillips JD, et al
     Disparities in access to multidisciplinary cancer consultations and treatment for early-stage non-small cell lung cancer patients: A SEER-Medicare analysis.
     Int J Radiat Oncol Biol Phys. 2024 Mar 13:S0360-3016(24)00426.
     PubMed     Abstract available
     
     
     
141. WALLS GM, Mistry H, Barlesi F, Bezjak A, et al
     Long-term outcomes after concurrent once- or twice-daily chemoradiation in limited-stage small-cell lung cancer: a brief report from the CONVERT trial.
     Int J Radiat Oncol Biol Phys. 2024 Mar 11:S0360-3016(24)00382.
     PubMed     Abstract available
     
     
     
142. YAN W, Ren Z, Chen X, Zhang R, et al
     Potential role of lymphocyte CD44 in determining treatment selection between stereotactic body radiotherapy and surgery for early-stage non-small-cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2024 Mar 4:S0360-3016(24)00356.
     PubMed     Abstract available
     
     
     
143. SHUJA M, Owen D
     What if Perioperative Therapy for Non-Small Cell Lung Cancer Renders Someone Inoperable?
     Int J Radiat Oncol Biol Phys. 2024;118:587.
     PubMed    
     
     
     
144. FARLEY A, Nelson B
     Neoadjuvant Chemoimmunotherapy for Initially Resectable Non-Small Cell Lung Cancer: Queen's Gambit or CheckMate?
     Int J Radiat Oncol Biol Phys. 2024;118:585-586.
     PubMed    
     
     
     February 2024
145. BASCHNAGEL AM, Flakus MJ, Wallat EM, Wuschner AE, et al
     A Phase 2 Randomized Clinical Trial Evaluating 4DCT Ventilation-based Functional Lung Avoidance Radiotherapy for Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00327.
     PubMed     Abstract available
     
     
     
146. WILLIAMS TM, Miller E, Welliver M, Brownstein J, et al
     A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00324.
     PubMed     Abstract available
     
     
     
147. HAN C, Qiu J, Bai L, Liu T, et al
     Pneumonitis risk after chemoradiotherapy with and without immunotherapy in patients with locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
     Int J Radiat Oncol Biol Phys. 2024 Feb 13:S0360-3016(24)00298.
     PubMed     Abstract available
     
     
     
148. KIM H, Lee E, Cho H, Kim E, et al
     Five-Day Spacing of Two Fractionated Ablative Radiotherapies Enhances Antitumor Immunity.
     Int J Radiat Oncol Biol Phys. 2024;118:498-511.
     PubMed     Abstract available
     
     
     January 2024
149. WANG J, Liu Y, Wu D, Tian C, et al
     OTUB1 targets CHK1 for deubiquitinating and stabilizing to facilitate lung cancer progression and radioresistance.
     Int J Radiat Oncol Biol Phys. 2024 Jan 22:S0360-3016(24)00246.
     PubMed     Abstract available
     
     
     
150. TRAN PT, Mouw KW
     SABR Today . . . and Tomorrow?
     Int J Radiat Oncol Biol Phys. 2024;118:11.
     PubMed    
     
     
     
151. WRIGHT JL, Bazan JG
     Time to Reconsider the Role of Diagnostic Chest Computed Tomography in Early-Stage Breast Cancer?
     Int J Radiat Oncol Biol Phys. 2024;118:104-106.
     PubMed    
     
     
     
152. CHEN Y, Pahlavian SH, Jacobs P, Neupane T, et al
     Systematic Evaluation of the Impact of Lung Segmentation Methods on 4-Dimensional Computed Tomography Ventilation Imaging Using a Large Patient Database.
     Int J Radiat Oncol Biol Phys. 2024;118:242-252.
     PubMed     Abstract available
     
     
     December 2023
153. BARTOLOMEO V, Cortiula F, Hendriks LEL, De Ruysscher D, et al
     A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2023 Dec 27:S0360-3016(23)08126.
     PubMed    
     
     
     
154. RIMNER A, Gelblum DY, Wu AJ, Shepherd AF, et al
     Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-small Cell Lung Cancer - A Phase I Dose Escalation Trial.
     Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08252.
     PubMed     Abstract available
     
     
     
155. RAN X, Wu BX, Shi M, Song L, et al
     CRISPR screen of druggable targets in small cell lung cancer identified ATM inhibitor (AZD1390) as a radiosensitizer.
     Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08245.
     PubMed     Abstract available
     
     
     
156. VAIOS EJ, Shenker RF, Hendrickson PG, Wan Z, et al
     Long-term Intracranial Outcomes with Combination Dual Immune-Checkpoint Blockade and SRS in Patients with Melanoma and NSCLC Brain Metastases.
     Int J Radiat Oncol Biol Phys. 2023 Dec 12:S0360-3016(23)08234.
     PubMed     Abstract available
     
     
     
157. BASSETTI MF, Morris BA, Sethakorn N, Lang JM, et al
     Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase Ib Trial.
     Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08166.
     PubMed     Abstract available
     
     
     
158. DUDAS D, Saghad PG, Dilling TJ, Perez BA, et al
     Deep Learning-Guided Dosimetry for Mitigating Local Failure of Non-Small Cell Lung Cancer Patients Receiving SBRT.
     Int J Radiat Oncol Biol Phys. 2023 Dec 4:S0360-3016(23)08185.
     PubMed     Abstract available
     
     
     
159. SAFAVI AH, Palma DA, Giuliani ME
     Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?
     Int J Radiat Oncol Biol Phys. 2023;117:1232-1235.
     PubMed    
     
     
     
160. SIVA S, Staehler M
     The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?
     Int J Radiat Oncol Biol Phys. 2023;117:1047.
     PubMed    
     
     
     
161. AHN J, Yeghiaian-Alvandi R, Hegi-Johnson F, Browne LH, et al
     SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life.
     Int J Radiat Oncol Biol Phys. 2023;117:1213-1221.
     PubMed     Abstract available
     
     
     
162. LINDBERG S, Grozman V, Karlsson K, Onjukka E, et al
     Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
     Int J Radiat Oncol Biol Phys. 2023;117:1222-1231.
     PubMed     Abstract available
     
     
     
163. LEE SH, Geng H, Arnold J, Caruana R, et al
     Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617.
     Int J Radiat Oncol Biol Phys. 2023;117:1270-1286.
     PubMed     Abstract available
     
     
     November 2023
164. MA J, Li Y, Yu H, Zhang J, et al
     The Role of Thoracic Vertebral Body Dosimetry in Minimizing Acute Hematologic Toxicities of Non-Small Cell Lung Cancer Patients Receiving Lung Radiotherapy and Immunotherapy.
     Int J Radiat Oncol Biol Phys. 2023 Nov 29:S0360-3016(23)08165.
     PubMed     Abstract available
     
     
     
165. VALDES G, Scholey J, Nano T, Gennatas ED, et al
     Predicting the impact of proton beam therapy technology on pulmonary toxicities for locally advanced lung cancer patients enrolled on the Proton Collaborative Group prospective clinical trial.
     Int J Radiat Oncol Biol Phys. 2023 Nov 22:S0360-3016(23)08154.
     PubMed     Abstract available
     
     
     
166. RAMESH S, Cifci A, Javeri S, Minne R, et al
     MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08139.
     PubMed     Abstract available
     
     
     
167. RITTER AR, Miller ED
     No Regrets About SABR for NETs.
     Int J Radiat Oncol Biol Phys. 2023;117:786.
     PubMed    
     
     
     
168. BUCKNELL NW, Hardcastle N, Woon B, Selbie L, et al
     The HI-FIVE Trial: A Prospective Trial Using 4-Dimensional (68)Ga Ventilation-Perfusion Positron Emission Tomography-Computed Tomography for Functional Lung Avoidance in Locally Advanced Non-small Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2023;117:887-892.
     PubMed     Abstract available
     
     
     
169. OMIDI A, Weiss E, Rosu-Bubulac M, Thomas G, et al
     Quantitative analysis of radiotherapy-induced cardiac and aortic sequelae in lung cancer patients via magnetic resonance imaging: A pilot study.
     Int J Radiat Oncol Biol Phys. 2023 Nov 9:S0360-3016(23)08045.
     PubMed     Abstract available
     
     
     
170. KUIPERS ME, van Doorn-Wink KCJ, Hiemstra PS, Slats AM, et al
     Predicting radiation-induced lung injury in lung cancer patients - challenges and opportunities: Predicting radiation-induced lung injury.
     Int J Radiat Oncol Biol Phys. 2023 Nov 2:S0360-3016(23)08049.
     PubMed     Abstract available
     
     
     
171. HEGI-JOHNSON F, Rudd SE, Wichmann CW, Akhurst T, et al
     PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study.
     Int J Radiat Oncol Biol Phys. 2023;117:675-682.
     PubMed    
     
     
     October 2023
172. GAUDREAULT M, Bucknell N, Woon B, Kron T, et al
     Dose-response relationship between radiotherapy and loss of lung perfusion comparing positron emission tomography and dual-energy computed tomography in non-small cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08047.
     PubMed     Abstract available
     
     
     
173. FRIEDES C, Iocolano M, Lee SH, Li B, et al
     Patterns of Failure, Low Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors: Patterns of Failure for after PACIFIC.
     Int J Radiat Oncol Biol Phys. 2023 Oct 20:S0360-3016(23)08010.
     PubMed     Abstract available
     
     
     
174. EDWARDS DM, Sankar K, Alseri A, Jiang R, et al
     Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer.
     Int J Radiat Oncol Biol Phys. 2023 Oct 2:S0360-3016(23)07971.
     PubMed     Abstract available
     
     
     September 2023
175. LIU F, Ververs JD, Farris MK, William Blackstock A Jr, et al
     Optimal Radiotherapy Fractionation Regimens for Early-Stage Non-Small-Cell Lung Cancer.
     Int J Radiat Oncol Biol Phys. 2023 Sep 19:S0360-3016(23)07929.
     PubMed     Abstract available
     
     
     
176. MENG Y, Sun H, Wang S, Yang H, et al
     Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic Radiotherapy in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
     Int J Radiat Oncol Biol Phys. 2023 Sep 14:S0360-3016(23)07917.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum